OPUS Health, a Division of Cegedim Relationship Management, Now Delivers Medication Loyalty and Adherence Solutions via e-Prescribing Systems

19.04.12 23:34 Uhr

Werte in diesem Artikel
Aktien

10,45 EUR -0,10 EUR -0,95%

Indizes

PKT PKT

Wer­bung

The OPUS Health division of Cegedim Relationship Management today announced the expansion of its patient acquisition and retention portfolio. OPUS Health’s newest solution allows pharmaceutical manufacturers to promote and deploy loyalty card programs within e-prescribing and electronic health records (EHRs) systems.

The solution enables higher promotion redemption by delivering loyalty card offers directly to a patient’s pharmacy through e-prescribing systems. The personalized offer is also printed for the benefit of the patient. Further, the OPUS Health solution enables pharmaceutical manufacturers to shift from the costly, time-consuming distribution process of physical loyalty cards to an electronic system that eliminates pharmacy obstacles for patients in receiving/redeeming loyalty card offers. As a result, pharmaceutical companies can now benefit from higher first-fill rates, ongoing adherence and brand loyalty through easy and accessible product promotions whose benefits go directly to patients.

OPUS Health has created the largest syndicated e-prescribing/EHR network with loyalty card promotion capabilities. OPUS Health is committed to expand accessibility to hundreds of e-prescribing/EHR providers.

Wer­bung

Deploy Electronic Loyalty Card Programs at the Point-of-Prescribing to Increase First-Fill Rates and Improve Medication Adherence

The digitalization of interactions between patients and health care professionals continues to holistically improve the quality and delivery of healthcare. With Federal incentives driving the e-prescribing/EHR trend, OPUS Health’s new offering is helping pharmaceutical companies deploy promotional services that increase accessibility to high-quality branded drugs and improve medication adherence. As reported, there are over 234,000 physicians ordering and sending over 326 million prescriptions electronically.

"By delivering a pharmaceutical company’s loyalty card promotion along with a patient’s prescription electronically, our latest solution will optimize companies’ loyalty programs in order to increase cost effectiveness and overall medication adherence”, explained Paul Kandle, Vice President and General Manager of OPUS Health, a division of Cegedim Relationship Management.

Wer­bung

About OPUS Health:

OPUS Health, a division of Cegedim Relationship Management, works with large and specialty pharmaceutical companies to design, implement and measure co-pay assistance and medication adherence programs. We offer clients optimized marketing solutions that not only increase brand trial and patient acquisition but also drive medication adherence. Our SmartTools family of products allows brand marketers to expand traditional patient capture and interaction points to reach more patients and create a lasting dialogue to drive adherence.

To learn more, please visit the OPUS Health website.

 
About Cegedim Relationship Management:

Cegedim Relationship Management is the Life Sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company’s innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Relationship Management enables more than 200,000 users in many of the world’s most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Relationship Management also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries. Cegedim Relationship Management is part of the France-based Cegedim S.A. Group.

To learn more, please visit: www.cegedim.com/rm.

 
About Cegedim:

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,200 people in more than 80 countries and generated revenue of €911 million in 2011. Cegedim SA is listed in Paris (EURONEXT: CGM).

To learn more, please visit: www.cegedim.com.

Ausgewählte Hebelprodukte auf Cegedim

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cegedim

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Cegedim S.A.

Wer­bung

Analysen zu Cegedim S.A.

DatumRatingAnalyst
09.11.2012Cegedim holdSociété Générale Group S.A. (SG)
21.09.2012Cegedim holdSociété Générale Group S.A. (SG)
20.09.2012Cegedim sellSociété Générale Group S.A. (SG)
10.09.2012Cegedim sellSociété Générale Group S.A. (SG)
02.08.2012Cegedim sellSociété Générale Group S.A. (SG)
DatumRatingAnalyst
11.04.2011Cegedim buySociété Générale Group S.A. (SG)
12.01.2011Cegedim buySociété Générale Group S.A. (SG)
DatumRatingAnalyst
09.11.2012Cegedim holdSociété Générale Group S.A. (SG)
21.09.2012Cegedim holdSociété Générale Group S.A. (SG)
04.04.2012Cegedim holdSociété Générale Group S.A. (SG)
13.01.2012Cegedim holdSociété Générale Group S.A. (SG)
08.11.2011Cegedim holdSociété Générale Group S.A. (SG)
DatumRatingAnalyst
20.09.2012Cegedim sellSociété Générale Group S.A. (SG)
10.09.2012Cegedim sellSociété Générale Group S.A. (SG)
02.08.2012Cegedim sellSociété Générale Group S.A. (SG)
02.04.2012Cegedim sellSociété Générale Group S.A. (SG)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cegedim S.A. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen